On Monday, Stifel analysts began coverage on Avalo Therapeutics Inc. (NASDAQ:AVTX), assigning the biopharmaceutical company a Buy rating and setting a price target of $36.00. According to InvestingPro ...

On Monday, Stifel analysts began coverage on Avalo Therapeutics Inc. (NASDAQ:AVTX), assigning the biopharmaceutical company a Buy rating and setting a price target of $36.00. According to ...

Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe to Barron's, click here. If you're a wealth managment professional and ...

Yes, you heard that right. Batman kicks kids. The genesis of the Michael Jordan meme dates back to 2016 and a friendly shooting competition between Michael Jordan and another NBA player ...

Stifel Nicolaus analyst Brad Reback maintained a Hold rating on Vertex (VERX – Research Report) today and set a price target of $31.00. The company’s shares closed yesterday at $36.45. Easily ...

Barry Bannister, Stifel chief equity strategist, joins CNBC's 'Squawk on the Street' to discuss market outlooks, how to position, and more. Student Loan Update as Trump Set to Order Department of ...

Easily identify stocks' risks and opportunities. Discover stocks' market position with detailed competitor analyses. Roy covers the Technology sector, focusing on stocks such as Nvidia, Celestica ...